角膜新生血管
渗透(战争)
化学
免疫系统
细胞生物学
新生血管
角膜上皮
肽
炎症
角膜炎症
药物输送
活性氧
纳米颗粒
生物物理学
清道夫受体
角膜
免疫荧光
紧密连接
癌症研究
巨噬细胞
纳米技术
上皮
吞噬作用
毒品携带者
生物医学工程
药理学
靶向给药
免疫学
作者
Wei Hu,Xueqi Lin,Jiaxi Xu,Bingbing Yao,Jinhui Dai,Min Sun,Zhen Fan
出处
期刊:Small
[Wiley]
日期:2026-03-30
卷期号:22 (29): e14865-e14865
标识
DOI:10.1002/smll.202514865
摘要
ABSTRACT Corneal neovascularization (CorNV), a leading cause of blindness, is notoriously difficult to treat because of the cornea's tight epithelial barrier and the accompanying inflammatory environment. Current therapies suffer from poor penetration and inadequate management of inflammation. To overcome these challenges, we developed a novel bioinspired nanoparticle. A VEGF‐inhibiting peptide was co‐assembled with Cu 2 + for stability and then modified with a reactive oxygen species (ROS) scavenger and a cell‐penetrating peptide. This multi‐functional design enables deep corneal penetration and targeted action. The resulting nanoparticle significantly prolongs ocular retention to 70 min. It achieved a remarkable penetration depth of 300 µm in a 3D corneal model, ensuring delivery to the site of disease. The nanoparticle demonstrated a dual mechanism of action; it effectively scavenged 60.31% of excess ROS and downregulated inflammation, reducing pro‐inflammatory macrophage polarization. This reshaped the immune microenvironment and potently suppressed angiogenesis, achieving 60.45% growth inhibition in the 3D model. In an animal model, the treatment successfully reduced abnormal blood vessel growth, with immunofluorescence confirming significantly lower expression of key inflammatory markers. This work presents a simple yet highly efficient strategy for deep ocular drug delivery, offering a potent therapeutic approach for CorNV and other oxidative stress‐ and inflammation‐related eye diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI